Free Trial
NASDAQ:PRPH

ProPhase Labs (PRPH) Stock Price, News & Analysis

ProPhase Labs logo
$0.33 +0.01 (+2.45%)
Closing price 05/2/2025 04:00 PM Eastern
Extended Trading
$0.33 +0.00 (+0.39%)
As of 05/2/2025 07:51 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

About ProPhase Labs Stock (NASDAQ:PRPH)

Key Stats

Today's Range
$0.32
$0.34
50-Day Range
$0.24
$0.48
52-Week Range
$0.22
$5.62
Volume
346,955 shs
Average Volume
2.66 million shs
Market Capitalization
$13.85 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.

Receive PRPH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for ProPhase Labs and its competitors with MarketBeat's FREE daily newsletter.

PRPH Stock News Headlines

ProPhase Labs reports FY24 EPS ($2.61) vs (98c) last year
Blackrock’s Sending THIS Crypto Higher on Purpose
While everyone's distracted by Bitcoin's moves, a stealth revolution is underway. One altcoin is quietly positioning itself to overthrow the entire banking system.
ProPhase Labs FY 2024 Earnings Preview
See More Headlines

PRPH Stock Analysis - Frequently Asked Questions

ProPhase Labs' stock was trading at $0.7571 at the start of the year. Since then, PRPH shares have decreased by 56.3% and is now trading at $0.3307.
View the best growth stocks for 2025 here
.

ProPhase Labs, Inc. (NASDAQ:PRPH) posted its quarterly earnings data on Thursday, May, 9th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.28) by $0.21. The company earned $3.63 million during the quarter, compared to analyst estimates of $9.86 million. ProPhase Labs had a negative net margin of 217.64% and a negative trailing twelve-month return on equity of 62.92%.
Read the conference call transcript
.

ProPhase Labs' top institutional investors include Cerity Partners LLC (0.22%) and Chapin Davis Inc. (0.19%).
View institutional ownership trends
.

Shares of PRPH stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that ProPhase Labs investors own include Meta Platforms (META), Pfizer (PFE), Valero Energy (VLO), CymaBay Therapeutics (CBAY), Catalyst Pharmaceuticals (CPRX) and Energy Transfer (ET).

Company Calendar

Last Earnings
5/09/2024
Today
5/04/2025
Next Earnings (Estimated)
5/08/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:PRPH
Employees
130
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-16,780,000.00
Net Margins
-217.64%
Pretax Margin
-298.21%

Debt

Sales & Book Value

Annual Sales
$6.77 million
Price / Cash Flow
N/A
Book Value
$2.74 per share
Price / Book
0.12

Miscellaneous

Free Float
18,932,000
Market Cap
$13.85 million
Optionable
Optionable
Beta
-0.56

Social Links

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report

This page (NASDAQ:PRPH) was last updated on 5/5/2025 by MarketBeat.com Staff
From Our Partners